메뉴 건너뛰기




Volumn 22, Issue 8, 2014, Pages 2529-2534

Structure-activity relationship of celecoxib and rofecoxib for the membrane permeabilizing activity

Author keywords

Celecoxib; COX 2 selectivity; Gastric adverse effect; Membrane permeabilization; Rofecoxib

Indexed keywords

1 (4 METHANESULFONYLPHENYL) 5 4 TOLYL 3 (TRIFLUOROMETHYL) 1H PYRAZOLE; 1 (4 METHANESULFONYLPHENYL) 5 PHENYL 3 (TRIFLUOROMETHYL) 1H PYRAZOLE; 1 (4 SULFONAMIDOPHENYL) 5 PHENYL 3 (TRIFLUOROMETHYL) 1H PYRAZOLE; 3 (4 METHYLPHENYL) 4 (4 METHANESULFONYLPHENYL) 2(5H) FURANONE; 3 (4 METHYLPHENYL) 4 (4 SULFONAMIDOPHENYL) 2(5H) FURANONE; 3 PHENYL 4 (4 SULFONAMIDOPHENYL) 2(5H) FURANONE; CALCEIN; CELECOXIB; CYCLOOXYGENASE 1; CYCLOOXYGENASE 2; FURANONE DERIVATIVE; PYRAZOLE DERIVATIVE; ROFECOXIB; UNCLASSIFIED DRUG; LACTONE; LIPID BILAYER; LIPOSOME; NONSTEROID ANTIINFLAMMATORY AGENT; PROSTAGLANDIN SYNTHASE INHIBITOR; PROTEIN BINDING; SULFONAMIDE; SULFONE;

EID: 84897993775     PISSN: 09680896     EISSN: 14643391     Source Type: Journal    
DOI: 10.1016/j.bmc.2014.02.032     Document Type: Article
Times cited : (18)

References (39)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.